United Kingdom Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
United Kingdom Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the United Kingdom Cell and Gene Therapy Manufacturing QC Market was valued at USD 50.09 Million in 2024 and is projected to reach USD 127.41 Million by 2028, expanding at a CAGR of 26.4% during the forecast period. This growth can be attributed to the widespread usage in industries such as agriculture, chemical, and energy where cell and gene therapies play a crucial role in enhancing productivity and efficiency. Additionally, factors like technological advancements are changing traditional production norms paving the way for a higher export potential. Importantly, the emergence of green production methods and sustainability in manufacturing practices have posed as potential trends in the market. The United Kingdom is proactively adapting to these evolutions, setting a strong foothold in the global cell and gene therapy manufacturing QC market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market Highlights
- By 2024, Cell Therapy represented the largest share of the Therapy Type market size.
- Gene Therapy is expected to remain the key growth driver within Therapy Type, registering the fastest CAGR during the forecast period.
- United Kingdom contributed 2.24% to the global cell and gene therapy manufacturing qc market size in 2024.
- By 2028, United States is forecasted to remain the largest global market for cell and gene therapy manufacturing qc market.
- In Europe, Germany is projected to capture the leading share of market by 2028.
- Among Europe markets, France is expected to post the fastest growth, reaching USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 50.09 Million |
| Market Size In 2028 | USD 127.41 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26.4% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
